Hepatitis B and C viruses and hepatocellular carcinoma

Clinics in Laboratory Medicine

Volumn 16, Issue 2, 1996, Pages 395-406

  Kew, M C ^a  

^a UNIVERSITY OF THE WITWATERSRAND MEDICAL SCHOOL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CARCINOGENICITY; CHRONIC DISEASE; GENE EXPRESSION; GENE INSERTION; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; LIVER CARCINOMA; MALIGNANT TRANSFORMATION; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSACTIVATION; VIRUS CELL INTERACTION;

EID: 0030004155     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0272-2712(18)30276-2     Document Type: Review

References (73)

1. Arbuthnot P. Kew M.C. Fitschen W. c-fos and c-myc oncogene expression in human hepatocellular carcinomas Anticancer Res 11 1991 921
2. Beasley R.P. Hwang L-Y Epidemiology of hepatocellular carcinoma Vyas GN Dienstag JL Hoofnagle JH Viral Hepatitis and Liver Disease 1984 Grune & Stratton Orlando 209
3. Benvegnu L. Fattovich G. Noventa F. Concurrent hepatitis B and C virus infection and the risk of hepatocellular carcinoma in cirrhosis Cancer 74 1994 2442
4. Beral V. Blum H. Buendia M-A Hepatitis Viruses, vol 59. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1994 International Agency for Research on Cancer Lyon 202
5. Botha J.F. Ritchie M.J.J. Dusheiko G.M. Hepatitis B virus carrier state in black children in Ovamboland: Role of perinatal and horizontal infection Lancet 2 1984 1210
6. Brechot C. Nalpas B. Courouce A.M. Evidence that hepatitis B virus has a role in liver cell carcinoma in alcoholic liver disease N Engl J Med 306 1982 1384
7. Bressac B. Kew M.C. Wands J.R. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa Nature 350 1991 429
8. Bruix J. Barrera J.M. Calvet X. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis Lancet 2 1989 1004
9. Buendia MA, Etiemble J, Degott C, et al: Primary hepatocellular carcinoma in transgenic mice carrying a woodchuck c-myc gene activated by hepadnaviral insertion. In Cilberto B, Cortese U, Schibier U, et al (eds): Gene Expression During Liver Differentiation and Disease. IRNBM, 1991, p 187
10. Chisari F.V. Klopchin K. Moriyama T. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B transgenic mice Cell 5 1989 1145
11. Chuang W-L Chang W-Y Lu S.N. The role of hepatitis B and C viruses in hepatocellular carcinoma in a hepatitis B endemic area: A case/control study Cancer 69 1992 2052
12. Cobden I. Bassendine M.F. James O.F.W. Hepatocellular carcinoma in north-east England: Importance of hepatitis B virus infection and ex-tropical miltary service Q J Med 60 1986 855
13. Colombo M. De Franchis R. Del Ninno E. Hepatocellular carcinoma in Italian patients with cirrhosis N Engl J Med 325 1991 675
14. de The H. Marchio A. Tiollais P. A novel steroid thyroid hormone receptor-related gene inappropriately expressed in human hepatocellular carcinoma Nature 330 1987 667
15. Di Mitri M.S. Poussin K. Baccarini P. HCV-associated liver cancer without cirrhosis Lancet 345 1995 413
16. Feitelsohn M.A. Zhu M. Duan L-X Hepatitis B X antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma Oncogene 8 1993 1109 1117
17. Fourel J. Trepo C. Bougueleret L. Frequent activation of n-myc genes by hepad-navirus insertion in woodchuck liver tumours Nature 347 1990 249
18. Fowler M.J.F. Greenfield C. Chu C.M. Integration of HBV DNA may not be a prerequisite for the maintenance of the state of malignant transformation J Hepatol 2 1986 218
19. Freeman B.A. Crapo J.D. Biology of disease: Free radicles and tissue injury Lab Invest 47 1982 412
20. Gerber M.A. Shieh Y.S.C. Shim K.S. Detection of replicative hepatitis C virus sequences in hepatocellular carcinoma Am J Pathol 141 1992 1271
21. Gerin J.L. Tennant B.C. Popper H. The woodchuck model of hepadnavirus infection and disease Brown F Chanock F Lerner R Vaccine ‘86: New Approaches to Immunization 1986 Cold Spring Harbor Laboratory Cold Spring Harbor NY 383
22. Haydon G.N. Jarvis L.M. Simmonds P. Association between chronic hepatitis C virus infection and hepatocellular carcinoma Lancet 345 1995 928
23. Hsu T-Y Moroy T. Etiemble J. Activation of c-myc by woodchuck hepatitis virus infection in hepatocellular carcinoma Cell 55 1988 627
24. Hsu T. Fourel J. Etiemble J. Integration of hepatitis B virus DNA near c-myc in woodchuck hepatocellular carcinoma Gastroenterol Jpn 25 suppl 2 1990 43
25. Kaklamani E. Trichopoulos D. Tzonou A. Hepatitis B and C viruses and their interaction in the origin of hepatocellular carcinoma JAMA 265 1991 1974
26. Kekule A.S. Lauer U. Meyer M. The preS/S region of integrated hepatitis B virus DNA encodes a transcriptional transactivator Nature 343 1990 457
27. Kew M.C. Hepatoma and the hepatitis B virus Vyas GN Cohen SN Schmid R Viral Hepatitis 1978 Franklin Institute Press Philadelphia 439
28. Kew M.C. The possible etiologic role of hepatitis B virus in hepatocellular carcinoma: Evidence from southern Africa Chisari FV Advances in Hepatitis Research 1984 Masson New York 203
29. Kew M.C. The hepatitis B virus and the genesis of hepatocellular carcinoma GI Cancer 1 1996 143 148
30. Kew M.C. Hepatitis C virus and hepatocellular carcinoma FEMS Microbiol Rev 14 1994 211
31. Kew M.C. Popper H. Relationship between hepatocellular carcinoma and cirrhosis Semin Liver Dis 4 1984 136
32. Kew MC: Hepatitis C virus infection in black patients with hepatocellular carcinoma in southern Africa. In Nishioka K (ed): Hepatitis C Virus and Hepatocellular Carcinoma. Princeton, Princeton Scientific Publishing, 1996, in press
33. Kim C.M. Koike K. Saito I. HBx gene of hepatitis B virus induces liver cancer in transgenic mice Nature 351 1991 317
34. Koff R.S. Dienstag J.L. Extrahepatic manifestations of hepatitis C and the association with alcoholic liver disease Semin Liver Dis 15 1995 101
35. Lee T-H Elledge S.J. Butei J.S. Hepatitis B virus X protein interacts with a probable cellular DNA repair protein J Virol 69 1995 1107 1114
36. Lehmann F.G. Martini G.A. Incidence of primary liver carcinoma in liver cirrhosis: 5 year prospective study Digestion 14 1976 530
37. Lohiya G. Pirkle H. Hoefs J. Hepatocellular carcinoma in young mentally retarded HBsAg carriers without cirrhosis Hepatology 5 1985 824
38. Marion P.L. Oshiro L.S. Popper H. Ground squirrel hepatitis and hepatocellular carcinoma Robinson WS Koike K Will H Hepadnaviruses 1987 Alan R. Liss New York 337
39. Matsubara K. Tokino T. Integration of hepatitis B virus DNA and its implications for hepatocarcinogenesis Mol Med Biol 7 1990 243
40. Momand S. Zambetti G.P. Olson D.C. The MDM-2 oncogene product forms a complex with the p53 protein and inhibits p53 mediated transactivation Cell 69 1992 1237 1245
41. Nakanuma Y. Ohto G. Morphology of cirrhosis and occurrence in hepatocellular carcinoma in alcoholics with and without HBsAg and in non-alcoholic HBsAg positive patients Liver 3 1983 231
42. Nalpas B. Driss F. Pol S. Association between hepatitis B and C virus infections in hepatocellular carcinoma and alcoholic liver disease J Hepatol 12 1991 70
43. Nousbaum J.B. Pol S. Nalpas B. Hepatitis C virus type lb (II) infection in France and Italy Ann Intern Med 122 1995 161
44. Obata H. Hayashi N. Moroike K. A prospective study of the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection Int J Cancer 25 1980 741
45. Ochiya T. Fugiyama J. Fukushige J. Molecular cloning of an oncogene from a human hepatocellular carcinoma Proc Natl Acad Sei USA 83 1986 4993
46. Onishi K. Iida S. Iwana S. The effect of habitual alcohol intake on the development of liver cirrhosis and hepatocellular carcinoma Cancer 49 1982 672
47. Parkin D.M. Piani P. Ferlay J. Estimates of the world wide incidence of 18 major cancers Int J Cancer 54 1993 594
48. Pasquinelli C. Bavani K. Chisari F.V. Multiple oncogenes and tumor suppressor genes are structurally and functionally intact during hepatocarcinogenesis in hepatitis B virus transgenic mice Cancer Res 52 1992 2823
49. Popper H. Roth L. Purcell R.H. Hepatocarcinogenicity of the woodchuck hepatitis virus Proc Natl Acad Sei USA 84 1987 866
50. Poynard T. Aubert A. Lazizi Y. Independent risk factors for hepatocellular carcinoma in French drinkers Hepatology 3 1991 896
51. Prince A.M. Szmuness W. Michon J. A case/control study of the association between primary liver cancer and hepatitis B infection in Senegal Int J Cancer 16 1975 376
52. Robinson W.S. Klote L. Aoki N. Hepadnaviruses in cirrhotic liver and hepatocellular carcinoma J Med Virol 31 1990 18
53. Rogier C.E. Sherman M. Shafritz D.A. Deletion in chromosome lip associated with hepatitis B virus integration site Science 230 1985 319 322
54. Shafritz D.A. Shouval D. Sherman H.I. Assessment of hepatitis B virus integration state in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous biopsies and postmortem liver tissues N Engl J Med 305 1981 1067
55. Shirakata Y. Kawada M. Fujiki Y. The X gene of hepatitis B virus induced growth stimulation and tumorigenic transformation in mouse NIH3T3 cells Jpn J Cancer Res 80 1989 617
56. Simonetti R.G. Camma C. Fiorella F. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis Ann Intern Med 116 1992 97
57. Simonetti R.G. Cottone M. Craxi A. Prevalence of antibodies to hepatitis C virus in hepatocellular carcinoma Lancet 2 1989 1338
58. Slagle B.L. Lee T-H Butei J.S. Hepatitis B virus and hepatocellular carcinoma Prog Med Virol 39 1992 167
59. Szmuness W. Hepatocellular carcinoma and hepatitis B virus: Evidence for a causal association Prog Med Virol 24 1978 40
60. Tarao K. Ohkawa S. Shimuzu A. Significance of hepatocellular proliferation in the development of hepatocellular carcinoma from antibody to hepatitis C virus-positive cirrhotic patients Cancer 73 1994 1149
61. Truant T. Antunovic J. Greenblatt J. Direct interaction of the hepatitis B virus X protein with p53 leads to the inhibition by HBX of p53 response element-directed transactivation J Virol 69 1995 1851
62. Tsai S-L Liaw Y-F Yeh C-T Cellular immune responses in patients with dual infection with hepatitis B and C viruses: Dominant role of hepatitis C virus Hepatology 21 1995 908
63. Tsukuma H. Hiyama T. Tanaka S. Risk factors for hepatocellular carcinoma among patients with chronic liver disease N Engl J Med 328 1993 1797
64. Ueda H. Ullrich S.J. Gangemii J.D. Functional inactivation but not structural mutation of p53 causes cancer Nature Genet 9 1995 41 47
65. Unsal H. Yakicier C. Marcais C. Genetic heterogeneity of hepatocellular carcinoma Proc Natl Acad Sei USA 91 1994 822 826
66. Vargas V. Castells L. Esteban J.I. High frequency of antibodies to hepatitis C virus among patients with hepatocellular carcinoma Ann Intern Med 112 1990 232
67. Walter E. Blum H.E. Meier P. Hepatocellular carcinoma in alcoholic liver disease: No evidence for a pathogenetic role for hepatitis B virus infection Hepatology 8 1988 745
68. Wang J.C. DNA topoisomerases Ann Rev Biochem 54 1985 665
69. Wang J. Chenivesse X. Henglein B. Hepatitis B virus integration in a cyclin A gene in hepatocellular carcinoma Nature 343 1990 555
70. Wang W. London W.T. Feitelsohn M.A. Hepatitis B X antigen in hepatitis B virus carrier patients with liver cancer Cancer Res 51 1991 4971 4977
71. Wang X.W. Forrester K. Feitelsohn M.A. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3 Proc Natl Acad Sei USA 91 1994 2230 2234
72. Witte O.N. Rosenberg N. Paskind M. Identification of an Abelson murine leukemia virus-encoded protein present in transformed fibroblasts and lymphoid cells Proc Natl Acad Sei USA 75 1978 2488
73. Yu M.C. Tong M.J. Coursaget P. Prevalence of hepatitis B and C viral markers in black and white patients with hepatocellular carcinoma J Natl Cancer Inst 82 1990 1038